Cardiovascular risks of ibuprofen versus naproxen: a target trial emulation

30 August 2025 (10:55 - 11:05)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Anne Bech-Drewes

Aarhus University Hospital, Aarhus (Denmark)

5 More presentations in this session

Presentation thumbnail

Lipid management in high cardiovascular risk patients without prior myocardial infarction or stroke - preliminary data from the VESALIUS-REAL global burden study

Doctor Q. Chan (Greater London, GB)

Abstract Slides Video

Presentation thumbnail

Lower rate of ischemic events with alirocumab in patients with atherosclerotic cardiovascular disease but without prior acute ischemic events

Professor D. Bhatt (New York City, US)

Abstract Slides Video

Presentation thumbnail

Aspirin for the primary prevention of major adverse cardiovascular events in patients with elevated lipoprotein(a): a meta-analysis

Doctor P. Lee (Bronx, US)

Abstract Slides Video

Presentation thumbnail

Efficacy of inclisiran in patients affected by familial hypercholesterolemia: data from CHOLINET Registry

Doctor C. Cotticelli (Naples, IT)

Abstract Slides Video

Presentation thumbnail

Cardiorenal protective therapy for CKD: Real world data from the Hellenic Cardiorenal Morbidity Snapshots (HECMOS)

Doctor I. Leontsinis (Athens, GR)

Abstract Slides Video

Access the full session

Session thumbnail

Improving pharmacotherapy in primary prevention

The Event

Event poster

ESC Congress 2025

30 August 2025 10:55 CET

You may be interested in

Congress Session

Improving pharmacotherapy in primary prevention

Congress Session

HOT LINE 5

Congress Presentation

Cardiovascular safety of non-steroidal anti-inflammatory drug use for gout: A Danish nationwide case-crossover study

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources